CR Sanjiu Medical & Pharmaceutical Co Ltd in Consumer Health (China)
CR Sanjiu Medical & Pharmaceutical, with a focus on addressing consumers’ needs in terms of self-medication, will continue to provide differentiated OTC products and services, aiming to be the leader in this area in China. The company will further extend its product lines, after the acquisition of Zhejiang Zhongyi Pharmaceutical in late 2015, to cover a wider range of consumer needs. Such mergers and acquisitions will continue in the forecast period, to enrich the company’s product offerings.
Euromonitor International Local Company Profiles are a concise set of briefings detailing the strategic direction taken by a company. Discover key contact details, the company background and their competitive positioning through this collection of snapshot company profiles.
Product coverage: Allergy Care, Herbal/Traditional Products, OTC, Paediatric Consumer Health, Sports Nutrition, Vitamins and Dietary Supplements, Weight Management and Wellbeing.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
Get a detailed picture of the Consumer Health market;
Pinpoint growth sectors and identify factors driving change;
Understand the competitive environment, the market’s major players and leading brands;
Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.